輸入代號或公司名稱後按 Enter
4161

聿新科

-0.20 (-0.89%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
22.2510成交張數12.29本益比1.35股價淨值比3.15%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.66832.2%1.860.3916.2%3.99%11.44%
2026Q10.3016.9%1.270.187.8%1.83%7.99%
2025Q40.45-10.8%1.230.2611.1%2.75%7.61%
2025Q30.4546.1%1.280.2612.2%2.83%8.13%
2025Q20.07-86.0%1.140.042.1%0.44%7.47%
2025Q10.26-17.2%1.580.157.6%1.64%10.37%
2024Q40.50-16.2%1.630.2912.6%3.23%10.88%
2024Q30.31-43.5%1.730.188.6%2.10%12.05%
2024Q20.50149.3%1.960.2913.9%3.43%14.12%
2024Q10.31129.8%1.660.188.2%2.18%12.20%
2023Q40.60110.0%1.490.3514.1%4.33%11.17%
2023Q30.558.3%1.170.3113.3%4.07%9.07%
2023Q20.201097.0%1.130.126.4%1.61%9.12%
2023Q10.13300.0%0.940.084.8%1.03%7.67%
2022Q40.29209.2%0.840.176.9%2.34%6.90%
2022Q30.51160.9%0.650.2912.7%4.20%5.16%
2022Q20.02-77.7%0.340.010.7%0.15%2.68%
2022Q10.030.0%0.400.021.3%0.28%3.22%
2021Q40.090.400.052.6%0.73%3.18%
2021Q30.190.020.115.6%1.49%0.15%
2021Q20.08-0.580.042.6%0.57%-4.55%
2021Q10.03-0.770.021.1%0.27%-6.03%
2020Q4-0.29-1.05-0.16-11.5%-2.29%-8.03%
2020Q3-0.40-420.0%-0.88-0.24-22.8%-3.37%-6.84%
2020Q2-0.11-230.0%-0.35-0.06-5.9%-0.89%-2.69%
2020Q1-0.24-3009.5%-0.16-0.14-10.5%-1.84%-1.17%
2019Q4-0.130.09-0.07-4.2%-0.92%0.67%
2019Q30.130.160.075.0%0.91%1.07%
2019Q20.08-89.0%-0.260.053.3%0.59%-2.04%
2019Q10.01-73.8%0.420.000.4%0.06%3.00%
2018Q4-0.060.45-0.04-2.4%-0.46%3.14%
2018Q3-0.300.39-0.18-15.1%-2.18%2.64%
2018Q20.771100.5%0.640.4641.0%5.39%4.35%
2018Q10.03-0.060.021.5%0.23%-0.40%
2017Q4-0.12-215.2%-0.55-0.07-6.2%-0.84%-3.54%
2017Q3-0.04-0.32-0.02-2.5%-0.25%-2.14%
2017Q20.06-60.0%-0.300.043.0%0.42%-2.00%
2017Q1-0.45-0.21-0.28-21.9%-2.76%-1.33%
2016Q40.100.130.064.5%0.59%
2016Q3-0.02-0.01-0.9%-0.11%